June 19, 2017 ENZYCHEM LIFESCIENCES ANNOUNCES INITIATION OF GLOBAL PHASE 2 TRIAL OF EC-18 IN PATIENTS WITH CHEMOTHERAPY INDUCED NEUTROPENIA(CIN) Explore further
